SENSEONICS HOLDINGS INC (SENS) Stock Fundamental Analysis
USA - NYSEARCA:SENS - US81727U1051 - Common Stock
6.1988 USD
-0.39 (-5.94%)
SENS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 189 industry peers in the Health Care Equipment & Supplies industry. While SENS seems to be doing ok healthwise, there are quite some concerns on its profitability. SENS is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year SENS has reported negative net income.
SENS had a negative operating cash flow in the past year.
In the past 5 years SENS reported 4 times negative net income.
SENS had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
SENS's Return On Assets of -45.39% is on the low side compared to the rest of the industry. SENS is outperformed by 64.02% of its industry peers.
With a Return On Equity value of -72.01%, SENS perfoms like the industry average, outperforming 41.27% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -45.39% | ||
| ROE | -72.01% | ||
| ROIC | N/A |
ROA(3y)-13.99%
ROA(5y)-136.34%
ROE(3y)-16.55%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
SENS has a Gross Margin of 17.77%. This is amonst the worse of the industry: SENS underperforms 80.95% of its industry peers.
SENS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 17.77% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
SENS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SENS has been increased compared to 1 year ago.
Compared to 5 years ago, SENS has more shares outstanding
SENS has a worse debt/assets ratio than last year.
2.2 Solvency
SENS has an Altman-Z score of -6.44. This is a bad value and indicates that SENS is not financially healthy and even has some risk of bankruptcy.
SENS has a worse Altman-Z score (-6.44) than 70.37% of its industry peers.
SENS has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
SENS's Debt to Equity ratio of 0.37 is in line compared to the rest of the industry. SENS outperforms 48.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.37 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -6.44 |
ROIC/WACCN/A
WACC8.56%
2.3 Liquidity
SENS has a Current Ratio of 9.58. This indicates that SENS is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of SENS (9.58) is better than 92.59% of its industry peers.
SENS has a Quick Ratio of 9.26. This indicates that SENS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 9.26, SENS belongs to the top of the industry, outperforming 92.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 9.58 | ||
| Quick Ratio | 9.26 |
3. Growth
3.1 Past
SENS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -561.54%.
SENS shows a small growth in Revenue. In the last year, the Revenue has grown by 5.94%.
The Revenue has been growing slightly by 1.08% on average over the past years.
EPS 1Y (TTM)-561.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1233.33%
Revenue 1Y (TTM)5.94%
Revenue growth 3Y18.01%
Revenue growth 5Y1.08%
Sales Q2Q%36.67%
3.2 Future
Based on estimates for the next years, SENS will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.87% on average per year.
The Revenue is expected to grow by 50.14% on average over the next years. This is a very strong growth
EPS Next Y-1187.15%
EPS Next 2Y-293.72%
EPS Next 3Y-139.62%
EPS Next 5Y14.87%
Revenue Next Year62.97%
Revenue Next 2Y68.18%
Revenue Next 3Y63.5%
Revenue Next 5Y50.14%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
SENS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SENS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
SENS's earnings are expected to decrease with -139.62% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-293.72%
EPS Next 3Y-139.62%
5. Dividend
5.1 Amount
SENS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSEARCA:SENS (11/13/2025, 2:01:59 PM)
6.1988
-0.39 (-5.94%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners18.56%
Inst Owner Change0.24%
Ins Owners2.78%
Ins Owner Change5.2%
Market Cap252.48M
Revenue(TTM)25.47M
Net Income(TTM)-68.21M
Analysts75.71
Price Target25.84 (316.85%)
Short Float %N/A
Short Ratio7.66
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.35%
Min EPS beat(2)1.96%
Max EPS beat(2)14.75%
EPS beat(4)3
Avg EPS beat(4)9.2%
Min EPS beat(4)-14%
Max EPS beat(4)34.09%
EPS beat(8)6
Avg EPS beat(8)7.97%
EPS beat(12)7
Avg EPS beat(12)-0.74%
EPS beat(16)11
Avg EPS beat(16)63.45%
Revenue beat(2)2
Avg Revenue beat(2)9.27%
Min Revenue beat(2)8.25%
Max Revenue beat(2)10.29%
Revenue beat(4)4
Avg Revenue beat(4)6.13%
Min Revenue beat(4)2.48%
Max Revenue beat(4)10.29%
Revenue beat(8)7
Avg Revenue beat(8)5.36%
Revenue beat(12)10
Avg Revenue beat(12)4.93%
Revenue beat(16)11
Avg Revenue beat(16)2.84%
PT rev (1m)1671.56%
PT rev (3m)1693.51%
EPS NQ rev (1m)-1426.9%
EPS NQ rev (3m)-1299.4%
EPS NY rev (1m)-1900.12%
EPS NY rev (3m)-1499.55%
Revenue NQ rev (1m)1.98%
Revenue NQ rev (3m)-8.21%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)0.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 9.91 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.67 | ||
| P/tB | 2.69 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.86
EYN/A
EPS(NY)-1.86
Fwd EYN/A
FCF(TTM)-1.35
FCFYN/A
OCF(TTM)-1.34
OCFYN/A
SpS0.63
BVpS2.33
TBVpS2.31
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -45.39% | ||
| ROE | -72.01% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 17.77% | ||
| FCFM | N/A |
ROA(3y)-13.99%
ROA(5y)-136.34%
ROE(3y)-16.55%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.17
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.37 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 22.67% | ||
| Cap/Sales | 1.53% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 9.58 | ||
| Quick Ratio | 9.26 | ||
| Altman-Z | -6.44 |
F-Score5
WACC8.56%
ROIC/WACCN/A
Cap/Depr(3y)70.29%
Cap/Depr(5y)48.74%
Cap/Sales(3y)4.48%
Cap/Sales(5y)3.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-561.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1233.33%
EPS Next Y-1187.15%
EPS Next 2Y-293.72%
EPS Next 3Y-139.62%
EPS Next 5Y14.87%
Revenue 1Y (TTM)5.94%
Revenue growth 3Y18.01%
Revenue growth 5Y1.08%
Sales Q2Q%36.67%
Revenue Next Year62.97%
Revenue Next 2Y68.18%
Revenue Next 3Y63.5%
Revenue Next 5Y50.14%
EBIT growth 1Y11.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year20.93%
EBIT Next 3Y12.25%
EBIT Next 5YN/A
FCF growth 1Y21.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y22.05%
OCF growth 3YN/A
OCF growth 5YN/A
SENSEONICS HOLDINGS INC / SENS FAQ
Can you provide the ChartMill fundamental rating for SENSEONICS HOLDINGS INC?
ChartMill assigns a fundamental rating of 2 / 10 to SENS.
What is the valuation status for SENS stock?
ChartMill assigns a valuation rating of 0 / 10 to SENSEONICS HOLDINGS INC (SENS). This can be considered as Overvalued.
How profitable is SENSEONICS HOLDINGS INC (SENS) stock?
SENSEONICS HOLDINGS INC (SENS) has a profitability rating of 0 / 10.